In yesterday’s Wall Street session, Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares traded at $0.08, up 26.62% from the previous session.
CDT stock price is now -18.29% away from the 50-day moving average and -93.33% away from the 200-day moving average. The market capitalization of the company currently stands at $9.41M.
In other news, Nirland Ltd, 10% Owner sold 1,500,000 shares of the company’s stock on Oct 03 ’24. The stock was sold for $156,450 at an average price of $0.10. Upon completion of the transaction, the 10% Owner now directly owns 8,400,000 shares in the company, valued at $0.67 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 04 ’24, 10% Owner Nirland Ltd sold 1,368,991 shares of the business’s stock. A total of $140,458 was realized by selling the stock at an average price of $0.10. This leaves the insider owning 7,031,009 shares of the company worth $0.56 million. A total of 39.12% of the company’s stock is owned by insiders.
During the past 12 months, Conduit Pharmaceuticals Inc has had a low of $0.05 and a high of $5.29. The fifty day moving average price for CDT is $0.09364 and a two-hundred day moving average price translates $1.15579 for the stock.
The latest earnings results from Conduit Pharmaceuticals Inc (NASDAQ: CDT) was released for 2024-06-30. The company reported revenue of $5.81 million for the quarter, compared to $0.43 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 1251.4 percent.
